← brief for 2026-08-13 · Slowing decline

Clonal hematopoietic mutations as a predictor of adverse outcomes in cytopenic patients with chronic kidney disease

Paper D Not peer reviewed Preclinical

Key takeaways

This study uses cell models to look at clonal mutations and kidney disease. No human trials found.

Who did this work

Suwannaporn Yaophrukchai (King Chulalongkorn Memorial Hospital) · Chantana Polprasert (Chulalongkorn University) · Sirorat Kobbuaklee (Chulalongkorn University) · Ponlapat Rojnuckarin (Chulalongkorn University) · Sunisa Kongkiatkamon (Chulalongkorn University)

Source

Paper · OpenAlex, CKD works · 2026-08-12
https://doi.org/10.1007/s44313-026-00161-2